CA2651646C - Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent - Google Patents

Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent Download PDF

Info

Publication number
CA2651646C
CA2651646C CA2651646A CA2651646A CA2651646C CA 2651646 C CA2651646 C CA 2651646C CA 2651646 A CA2651646 A CA 2651646A CA 2651646 A CA2651646 A CA 2651646A CA 2651646 C CA2651646 C CA 2651646C
Authority
CA
Canada
Prior art keywords
acid
solvating system
gallium
metal ion
solvating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2651646A
Other languages
English (en)
French (fr)
Other versions
CA2651646A1 (en
Inventor
Matthew F. Myntti
Dana A. Oliver
Cecil O. Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Xomed LLC
Original Assignee
Medtronic Xomed LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/431,495 external-priority patent/US20070264296A1/en
Application filed by Medtronic Xomed LLC filed Critical Medtronic Xomed LLC
Publication of CA2651646A1 publication Critical patent/CA2651646A1/en
Application granted granted Critical
Publication of CA2651646C publication Critical patent/CA2651646C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2651646A 2006-05-10 2007-05-08 Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent Expired - Fee Related CA2651646C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/431,495 US20070264296A1 (en) 2006-05-10 2006-05-10 Biofilm extracellular polysachharide solvating system
US11/431,495 2006-05-10
US11/739,508 US7976873B2 (en) 2006-05-10 2007-04-24 Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US11/739,508 2007-04-24
PCT/US2007/068477 WO2007134055A1 (en) 2006-05-10 2007-05-08 Antibacterial extracellular polysaccharide solvating system

Publications (2)

Publication Number Publication Date
CA2651646A1 CA2651646A1 (en) 2007-11-22
CA2651646C true CA2651646C (en) 2015-01-27

Family

ID=38458463

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2651646A Expired - Fee Related CA2651646C (en) 2006-05-10 2007-05-08 Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent

Country Status (9)

Country Link
US (1) US7976873B2 (https=)
EP (1) EP2029232B1 (https=)
JP (2) JP5912218B2 (https=)
KR (1) KR101453011B1 (https=)
CN (1) CN104815328A (https=)
AU (1) AU2007249413B2 (https=)
CA (1) CA2651646C (https=)
ES (1) ES2650974T3 (https=)
WO (1) WO2007134055A1 (https=)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007208169A1 (en) * 2006-01-30 2007-08-02 Lawrence R. Bernstein Use of gallium to treat biofilm-associated infectons
US20070264296A1 (en) 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
US20090054881A1 (en) * 2007-06-14 2009-02-26 Yosef Krespi Mammalian biofilm treatment processes and instruments
CA2727432C (en) 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
EP2346324A4 (en) * 2008-10-06 2012-10-10 Microbial Defense Systems Llc ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
DE102008064481A1 (de) * 2008-12-18 2010-08-12 Bode Chemie Gmbh Kombinierte Desinfektions- und Dekontaminationsmittel mit erhöhter Wirksamkeit
US10653133B2 (en) 2011-05-10 2020-05-19 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
ES2756848T3 (es) 2011-10-08 2020-04-27 Next Science IP Holdings Pty Ltd Composiciones antimicrobianas y métodos que las emplean
CA3085086C (en) 2011-12-06 2023-08-08 Delta Faucet Company Ozone distribution in a faucet
US9707520B2 (en) 2012-01-18 2017-07-18 Nch Corporation Composition, system, and method for treating water systems
EP2807323B1 (en) 2012-01-18 2020-05-13 NCH Corporation Composition and method for treating water systems
US9716253B2 (en) * 2012-03-23 2017-07-25 Lg Chem, Ltd. Battery case for secondary battery
CN103484392A (zh) * 2012-06-13 2014-01-01 中国海洋大学 用Pseudomonas fluorescens PGM37菌株生产葡甘聚糖
AU2014259670B2 (en) 2013-05-02 2017-11-02 Osartis Gmbh High osmolarity antimicrobial composition containing one or more organic solvents
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9506016B2 (en) 2013-11-06 2016-11-29 Nch Corporation Composition and method for treating water systems
US9441190B2 (en) 2013-11-06 2016-09-13 Nch Corporation Composition and method for treating water systems
US9848604B2 (en) * 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
US9744192B2 (en) 2015-03-16 2017-08-29 Lee A. Flippin Methods of treating chronic rhinosinusitis
HK1253401A1 (zh) 2015-07-17 2019-06-14 贴近科学Ip控股私人有限公司 具有抗内生孢子功效的抗微生物组合物
CN107922892A (zh) 2015-08-07 2018-04-17 贴近科学Ip控股私人有限公司 具有抗内生孢子功效的抗微生物组合物
CN108463437B (zh) 2015-12-21 2022-07-08 德尔塔阀门公司 包括消毒装置的流体输送系统
CN105770999B (zh) * 2016-03-03 2019-01-29 宁夏大学 一种消除细菌生物被膜的复合生物材料
AU2017290082A1 (en) 2016-06-30 2018-12-13 Next Science IP Holdings Pty Ltd Antimicrobial compositions and methods employing same
EP3710030A4 (en) 2017-11-19 2020-12-23 Next Science IP Holdings Pty Ltd COMPOSITIONS AND METHODS FOR TREATMENT OF INTERVERTEBRAL DISCS
WO2019213396A1 (en) * 2018-05-03 2019-11-07 Jaim Nulman Formulations and delivery methods for reduction and elimination of pathogen induced inflammations in the human body
US11717139B2 (en) 2019-06-19 2023-08-08 Bolt Medical, Inc. Plasma creation via nonaqueous optical breakdown of laser pulse energy for breakup of vascular calcium
WO2020256898A1 (en) 2019-06-19 2020-12-24 Boston Scientific Scimed, Inc. Balloon surface photoacoustic pressure wave generation to disrupt vascular lesions
US12402946B2 (en) 2019-06-19 2025-09-02 Boston Scientific Scimed, Inc. Breakdown of laser pulse energy for breakup of vascular calcium
US11660427B2 (en) 2019-06-24 2023-05-30 Boston Scientific Scimed, Inc. Superheating system for inertial impulse generation to disrupt vascular lesions
US12280223B2 (en) 2019-06-26 2025-04-22 Boston Scientific Scimed, Inc. Focusing element for plasma system to disrupt vascular lesions
US11583339B2 (en) 2019-10-31 2023-02-21 Bolt Medical, Inc. Asymmetrical balloon for intravascular lithotripsy device and method
US12102384B2 (en) 2019-11-13 2024-10-01 Bolt Medical, Inc. Dynamic intravascular lithotripsy device with movable energy guide
US12274497B2 (en) 2019-12-18 2025-04-15 Bolt Medical, Inc. Multiplexer for laser-driven intravascular lithotripsy device
CN115515542B (zh) * 2020-01-24 2026-02-06 斯皮拉尔诊疗有限公司 用于耳科的装置、系统和方法
US12446961B2 (en) 2020-02-10 2025-10-21 Bolt Medical, Inc. System and method for pressure monitoring within a catheter system
US11672599B2 (en) 2020-03-09 2023-06-13 Bolt Medical, Inc. Acoustic performance monitoring system and method within intravascular lithotripsy device
WO2021188233A1 (en) 2020-03-18 2021-09-23 Bolt Medical, Inc. Optical analyzer assembly and method for intravascular lithotripsy device
US11707323B2 (en) 2020-04-03 2023-07-25 Bolt Medical, Inc. Electrical analyzer assembly for intravascular lithotripsy device
US20210353359A1 (en) 2020-05-12 2021-11-18 Bolt Medical, Inc. Active alignment system and method for optimizing optical coupling of multiplexer for laser-driven intravascular lithotripsy device
US12295654B2 (en) 2020-06-03 2025-05-13 Boston Scientific Scimed, Inc. System and method for maintaining balloon integrity within intravascular lithotripsy device with plasma generator
US12207870B2 (en) 2020-06-15 2025-01-28 Boston Scientific Scimed, Inc. Spectroscopic tissue identification for balloon intravascular lithotripsy guidance
MX2023004219A (es) 2020-10-14 2023-12-01 Next Science IP Holdings Pty Ltd Composicion desinfectante de superficies duras.
US12016610B2 (en) 2020-12-11 2024-06-25 Bolt Medical, Inc. Catheter system for valvuloplasty procedure
US11672773B2 (en) 2020-12-13 2023-06-13 Next Science IP Holdings Pty Ltd Methods for treating ciliated cavities
US11672585B2 (en) 2021-01-12 2023-06-13 Bolt Medical, Inc. Balloon assembly for valvuloplasty catheter system
WO2022154954A1 (en) 2021-01-12 2022-07-21 Bolt Medical, Inc. Balloon assembly for valvuloplasty catheter system
US11648057B2 (en) 2021-05-10 2023-05-16 Bolt Medical, Inc. Optical analyzer assembly with safety shutdown system for intravascular lithotripsy device
US11806075B2 (en) 2021-06-07 2023-11-07 Bolt Medical, Inc. Active alignment system and method for laser optical coupling
US11839391B2 (en) 2021-12-14 2023-12-12 Bolt Medical, Inc. Optical emitter housing assembly for intravascular lithotripsy device
US12533184B2 (en) 2022-04-02 2026-01-27 Boston Scientific Scimed, Inc. Optical connector assembly for intravascular lithotripsy device
US12059430B2 (en) 2022-09-29 2024-08-13 Adora Animal Health Corporation Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB983130A (en) 1962-08-06 1965-02-10 Mundipharma Ag Improvements in preparations for the removal of wax from the ear
US4002775A (en) 1973-07-09 1977-01-11 Kabara Jon J Fatty acids and derivatives of antimicrobial agents
CA1052273A (en) 1975-12-18 1979-04-10 Edwin B. Michaels Antimicrobial compositions
SU1128917A1 (ru) 1980-12-24 1984-12-15 Кишиневский государственный медицинский институт Способ лечени пародонтоза
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5208257A (en) 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5290552A (en) 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
SU1699430A1 (ru) 1989-03-03 1991-12-23 Кишиневский государственный медицинский институт Способ лечени пародонтита
EP0466397A3 (en) 1990-07-10 1992-05-06 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters
US5662913A (en) 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
CA2108008C (en) 1991-04-10 1999-05-04 Christopher C. Capelli Antimicrobial compositions useful for medical applications
GB9204175D0 (en) * 1992-02-27 1992-04-08 Unilever Plc Cleansing composition
US5229103A (en) 1992-04-30 1993-07-20 Hydrodent Laboratories, Inc. Antiplaque mouthwash concentrate
IT1260154B (it) 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
CN1091315A (zh) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5336163A (en) 1993-01-06 1994-08-09 Smith & Nephew Richards, Inc. Expandable nasal stent
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5480658A (en) 1993-07-23 1996-01-02 Melman; Steven A. Ear and skin cleanser
FR2710529A1 (fr) 1993-09-29 1995-04-07 Zirinis Phedon Gel aqueux à usage nasal, pellets, et leur procédé de préparation.
US6544761B2 (en) 1994-12-13 2003-04-08 Human Genome Sciences, Inc. Human tissue inhibitor of metalloproteinase-4
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US5817303A (en) 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
SI9620106B (sl) 1995-08-29 2005-12-31 Fidia Advanced Biopolymers Srl Bioloski materiali za preprecevanje post-kirurskih adhezij, ki se sestojijo iz derivatov hialuronske kisline
US5601594A (en) 1995-09-14 1997-02-11 Best; Barry D. Nasal stent
FI955389A0 (fi) 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
US6423694B1 (en) 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
US5693065A (en) 1996-06-25 1997-12-02 Rains, Iii; B. Manrin Frontal sinus stent
JPH1072342A (ja) * 1996-06-27 1998-03-17 Senju Pharmaceut Co Ltd 界面活性剤の刺激性低下方法及び低刺激性水性組成物
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6203822B1 (en) * 1996-09-03 2001-03-20 University Of Iowa Research Foundation Gallium-containing compounds for the treatment of infections caused by intracellular pathogens and pathogens causing chronic pulmonary infection
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
KR20000048812A (ko) 1996-10-01 2000-07-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 병원성 유기체에 의한 비인두 전이증식 관련 세균 감염 치료용약제를 제조하기 위한 뮤피로신의 용도
IT1287967B1 (it) 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S Preparazioni farmaceutiche per uso anestetico locale
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US5709546A (en) 1996-11-27 1998-01-20 Waggoner; Mark B. Water sanitizing system and process
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
US6891037B1 (en) 1997-01-24 2005-05-10 Schweiz. Serum- & Impfinstitut Bern Method for the isolation of polysaccharides
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US5925334A (en) 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
WO1999027905A1 (en) 1997-12-02 1999-06-10 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Compositions for nasal administration
US5895781A (en) 1997-12-22 1999-04-20 S. C. Johnson & Son, Inc. Cleaning compositions for ceramic and porcelain surfaces and related methods
ES2191355T3 (es) 1997-12-24 2003-09-01 Britannia Pharmaceuticals Ltd Uso de un tensioactivo para la preparacion de un medicamento para el tratamiento de trastornos del oido medio.
US6541116B2 (en) 1998-01-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Superoxide dismutase or superoxide dismutase mimic coating for an intracorporeal medical device
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
US6623521B2 (en) 1998-02-17 2003-09-23 Md3, Inc. Expandable stent with sliding and locking radial elements
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6824793B1 (en) 1998-06-01 2004-11-30 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
US20030079758A1 (en) 1998-06-03 2003-05-01 Siegel Phyllis B. Process and composition for removing biofilm
US20020022588A1 (en) 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
GB9822170D0 (en) 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
JP2002529545A (ja) 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
US8197461B1 (en) 1998-12-04 2012-06-12 Durect Corporation Controlled release system for delivering therapeutic agents into the inner ear
US6375963B1 (en) 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US20020061281A1 (en) 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA2385150C (en) 1999-09-15 2010-11-23 Cryolife, Inc. Vascular coating composition
WO2001022936A1 (en) 1999-09-24 2001-04-05 Alcon Universal Ltd. Topical suspension formulations containing ciprofloxacin and dexamethasone
US6533749B1 (en) 1999-09-24 2003-03-18 Medtronic Xomed, Inc. Angled rotary tissue cutting instrument with flexible inner member
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
GB0002229D0 (en) * 2000-02-01 2000-03-22 Reckitt & Colman Inc Improvements in or relating to organic compositions
MXPA02008373A (es) 2000-02-28 2002-12-13 Procter & Gamble Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de las mismas.
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US20030009213A1 (en) 2000-03-13 2003-01-09 Jun Yang Stent having cover with drug delivery capability
AU6343701A (en) 2000-06-05 2001-12-17 S C Johnson Biocidal cleaner composition
US20020029015A1 (en) 2000-07-04 2002-03-07 Edoardo Camenzind Device for administering a composition in a duct of a human or animal body
US6953772B2 (en) 2000-07-18 2005-10-11 Lopes John A Concentrated sanitizing compositions for cleaning food and food contact surfaces
AUPQ893200A0 (en) * 2000-07-21 2000-08-17 Whiteley, Reginald K. Medical residue treatment
US20030133883A1 (en) 2001-06-14 2003-07-17 Finnegan Mary Beth Oral care compositions containing grapefruit seed extract
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6623513B2 (en) 2001-01-19 2003-09-23 Advanced Photodynamic Technologies, Inc. Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
DE10105592A1 (de) 2001-02-06 2002-08-08 Achim Goepferich Platzhalter zur Arzneistofffreigabe in der Stirnhöhle
DE60219560T2 (de) * 2001-02-26 2008-01-03 Mitsubishi Jidosha Kogyo K.K. Katalysator zur abgasreinigung
US6610314B2 (en) 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6962813B2 (en) 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
CA2459471C (en) * 2001-09-13 2010-02-02 Jerry W. Schoen Method of continuously casting electrical steel strip with controlled spray cooling
RU2295346C2 (ru) 2001-09-21 2007-03-20 Алькон, Инк. Способ лечения инфекций среднего уха
US20030064000A1 (en) 2001-09-24 2003-04-03 Wilson Burgess Methods of sterilizing biological mixtures using stabilizer mixtures
AU2003205227A1 (en) 2002-01-18 2003-09-02 Emory University Phthalocyanine and porphyrazine pharmaceutical compositions
US20050042240A1 (en) 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US20030180181A1 (en) 2002-02-01 2003-09-25 Teri Greib Methods for sterilizing tissue
RU2228203C2 (ru) 2002-04-12 2004-05-10 ООО "Наука-Сервис-Центр" Ранозаживляющий материал
EP1499341A4 (en) 2002-04-18 2010-10-27 Univ Iowa Res Found METHOD FOR INHIBITING AND TREATING BACTERIAL BIOFILMS WITH METAL CHELATE IMAGES
US6919348B2 (en) 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
EP1374856A1 (en) 2002-06-18 2004-01-02 Impetus AG Oily thixotropic nasal spray
US7105175B2 (en) 2002-06-19 2006-09-12 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled delivery of a therapeutic agent
WO2004024187A2 (en) 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20050064508A1 (en) 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
WO2004026267A2 (en) 2002-09-23 2004-04-01 Genta Inc. Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them
CN1684722A (zh) 2002-09-30 2005-10-19 博士伦公司 减少细菌在生物材料和生物医学装置上的粘附
US6770729B2 (en) 2002-09-30 2004-08-03 Medtronic Minimed, Inc. Polymer compositions containing bioactive agents and methods for their use
US20040110738A1 (en) 2002-10-22 2004-06-10 Gillis Scott H. Prophylactic treatment methods
US20040101506A1 (en) * 2002-11-25 2004-05-27 Fust Charles A. Composition for the prevention and treatment of inflammation of the ear
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US7491234B2 (en) 2002-12-03 2009-02-17 Boston Scientific Scimed, Inc. Medical devices for delivery of therapeutic agents
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
JP2006520786A (ja) 2003-03-14 2006-09-14 シネクサス， インコーポレイテッド 徐放性治療剤の洞送達
US20040214753A1 (en) 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20040213758A1 (en) 2003-04-23 2004-10-28 Rimon Therapeutics Ltd. Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases
US7090882B2 (en) 2003-06-12 2006-08-15 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
US20050003007A1 (en) 2003-07-02 2005-01-06 Michele Boix Method of sterilization of polymeric microparticles
US7341983B2 (en) 2003-08-04 2008-03-11 Ecolab Inc. Antimicrobial compositions including carboxylic acids and alkoxylated amines
AU2004264974A1 (en) 2003-08-15 2005-02-24 Arius Two, Inc. Adhesive bioerodible transmucosal drug delivery system
US20050080396A1 (en) 2003-10-03 2005-04-14 Michael Rontal Method and apparatus for the ultrasonic cleaning of biofilm coated surfaces
DE10347994A1 (de) 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
AU2004296178B2 (en) 2003-12-04 2011-03-24 The United States Of America As Represented By The Department Of Veterans Affairs Gallium inhibits biofilm formation
ZA200605583B (en) 2003-12-17 2009-06-24 Titan Pharmaceuticals Inc Use of gallium to treat inflammatory arthritis
JP2007517042A (ja) 2003-12-30 2007-06-28 デュレクト コーポレーション 活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント
US7541320B2 (en) * 2004-01-23 2009-06-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild, viscous cleansing composition with versatile compatibility and enhanced conditioning
EP1729676A1 (en) 2004-03-15 2006-12-13 Durect Corporation Pharmaceutical compositions for administration to a sinus
AU2005231417A1 (en) 2004-04-02 2005-10-20 Baylor College Of Medicine Novel modification of medical prostheses
US7803150B2 (en) 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US7410480B2 (en) 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US20050282722A1 (en) * 2004-06-16 2005-12-22 Mcreynolds Kent B Two part cleaning composition
US7494963B2 (en) 2004-08-11 2009-02-24 Delaval Holding Ab Non-chlorinated concentrated all-in-one acid detergent and method for using the same
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
EP2258837A1 (en) 2004-09-10 2010-12-08 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
US20060079420A1 (en) * 2004-10-08 2006-04-13 Wagner Julie A Multi-phase personal cleansing composition
EP1858506A2 (en) * 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
WO2006099386A2 (en) 2005-03-11 2006-09-21 Massachusetts Institute Of Technology Synthesis and use of colloidal iii-v nanoparticles
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7998404B2 (en) 2006-07-13 2011-08-16 Advanced Cardiovascular Systems, Inc. Reduced temperature sterilization of stents
CA2676081C (en) 2007-02-08 2015-07-07 Medtronic Xomed, Inc. Solvating system and sealant for medical use

Also Published As

Publication number Publication date
WO2007134055A1 (en) 2007-11-22
EP2029232A1 (en) 2009-03-04
JP5912218B2 (ja) 2016-04-27
ES2650974T3 (es) 2018-01-23
EP2029232B1 (en) 2017-09-20
KR20090005162A (ko) 2009-01-12
US7976873B2 (en) 2011-07-12
CN104815328A (zh) 2015-08-05
JP2014240419A (ja) 2014-12-25
US20070264353A1 (en) 2007-11-15
JP2009536666A (ja) 2009-10-15
AU2007249413A1 (en) 2007-11-22
AU2007249413B2 (en) 2012-08-30
CA2651646A1 (en) 2007-11-22
KR101453011B1 (ko) 2014-10-21

Similar Documents

Publication Publication Date Title
CA2651646C (en) Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent
US7959943B2 (en) Solvating system and sealant for medical use in the middle or inner ear
CN101443079A (zh) 抗菌的细胞外多糖溶剂化体系
US8691288B2 (en) Gallium-containing sealant for medical use
CN101626762B (zh) 用于医药用途的溶剂化体系及密封剂
CA2727432C (en) Method for treating chronic wounds with an extracellular polymeric substance solvating system
CA2860295C (en) Solvating system and sealant for medical use
AU2013211488B2 (en) Solvating system and sealant for medical use
HK1130717A (en) Antibacterial extracellular polysaccharide solvating system
RU2418574C2 (ru) Сольватирующая система и герметик для медицинского применения

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20210510